NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
788,087
788,087
451,240
161,626
15,000
Cost of Revenue
7,428
7,428
4,889
1,254
-
Gross Profit
780,659
780,659
446,351
160,372
-
Operating Expenses
Research Development
354,314
354,314
160,524
121,827
94,291
Selling General and Administrative
354,062
354,062
248,932
169,906
68,081
Total Operating Expenses
708,376
708,376
409,456
291,733
162,372
Operating Income or Loss
72,283
72,283
36,895
-131,361
-147,372
Interest Expense
31,963
31,963
30,530
19,523
-
Total Other Income/Expenses Net
6,222
6,222
15,476
8,342
3,444
Income Before Tax
46,542
46,542
21,841
-142,542
-141,090
Income Tax Expense
9,530
9,530
730
-
-
Income from Continuing Operations
37,012
37,012
21,111
-142,542
-141,090
Net Income
37,012
37,012
21,111
-142,542
-141,090
Net Income available to common shareholders
37,012
37,012
21,111
-142,542
-141,090
Basic EPS
-
-
0.23
-1.62
-1.63
Diluted EPS
-
-
0.22
-1.62
-1.63
Basic Average Shares
-
-
90,235
88,089
86,713
Diluted Average Shares
-
-
95,386
88,089
86,713
EBITDA
-
85,957
56,395
-120,619
-145,919